articleThe LancetSep 1, 2007Closed access

Dabigatran etexilate versus enoxaparin for prevention of venous thromboembolism after total hip replacement: a randomised, double-blind, non-inferiority trial

BIBengt I. ErikssonOEOla E. DahlNRNadia RosencherAKAndreas KurthCNC. Niek van Dijk

Sahlgrenska University Hospital · Thrombosis Research Institute · +10 more institutions

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

1,115
total citations
FWCI
67.48
Percentile
100%
References
29
Citations per year

Authors

11

Topics & keywords

Topics
Keywords
  • Medicine
  • Dabigatran
  • Direct thrombin inhibitor
  • Placebo
  • Anesthesia
  • Surgery
  • Randomized controlled trial
  • Hip replacement
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.